Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.05% cyclosporine eye drops (II) for dry eye after SMILE refractive surgery
ChiCTR2400084341Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cyclosporine in dry eye syndrome (DED) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: OSDI. Planned start May 2024; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2400084341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084341.